Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NeuroAdjuvants

NeuroAdjuvants
2005 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
6 INVESTORS
Description

Developer of peptide-based therapeutics. The company's peptide-based therapeutics is produced by research and development of neuropeptide-based therapeutics for the treatment of neurological, psychiatric, metabolic and inflammatory disorders.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 417 Wakara Way
  • Suite 3111
  • Salt Lake City, UT 84108
  • United States

+1 (801) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NeuroAdjuvants’s full profile, request a free trial.

NeuroAdjuvants Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 26-Mar-2009 00.00 Completed Startup
2. Early Stage VC (Series A2) 27-Jun-2007 000000 00.00 00.00 Completed Startup
1. Early Stage VC (Series A1) 22-Jan-2007 $200K $200K 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NeuroAdjuvants Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A2 000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A1 000,000 00.000000 00 00 00 00 0.000
To view this company’s complete Cap Table, request access »

NeuroAdjuvants Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Epilepsy Foundation Corporation 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
University of Utah Endowment Limited Partner 000 0000 000000 0
University of Utah Research Foundation Angel Group 000 0000 000000 0
Utah Centers of Excellence Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

NeuroAdjuvants Executive Team (2)

Name Title Board
Seat
Contact
Info
Grzegorz Bulaj Ph.D Co-Founder & Advisor
Steve White Ph.D Scientific Co-Founder

NeuroAdjuvants Board Members (1)

Name Representing Role Since Contact
Info
Hunter Jackson Ph.D Self Board Member 000 0000